Immunotherapy and the Interventional Oncologist: Challenges and Opportunities—A Society of Interventional Oncology White Paper

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Interventional oncology is a subspecialty field of interventional radiology that addresses the diagnosis and treatment of cancer and cancer-related problems by using targeted minimally invasive procedures performed with image guidance. Immuno-oncology is an innovative area of cancer research and practice that seeks to help the patient’s own immune system fight cancer. Both interventional oncology and immuno-oncology can potentially play a pivotal role in cancer management plans when used alongside medical, surgical, and radiation oncology in the care of cancer patients.

Related collections

Author and article information

Contributors

Joseph P. Erinjeri:

ORCID: http://orcid.org/0000-0003-1876-727X

Journal

Journal ID (nlm-ta): Radiology

Journal ID (iso-abbrev): Radiology

Journal ID (publisher-id): Radiology

Title: Radiology

Publisher: Radiological Society of North America

ISSN (Print): 0033-8419

ISSN (Electronic): 1527-1315

Publication date (Print): July 2019

Publication date (Electronic): 23 April 2019

Publication date PMC-release: 1 July 2020

Volume: 292

Issue: 1

Pages: 25-34

Affiliations

[1]From the Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, H-118, New York, NY 10065 (J.P.E.); Department of Radiology and Imaging Sciences, University of Utah School of Medicine, Salt Lake City, Utah (G.C.F.); Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands (G.J.A., M.d.B.); Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass (M.A.); Division of Vascular and Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (J.C.); Department of Radiodiagnostic and Interventional Radiology, University of Lausanne, Lausanne, Switzerland (R.D.); Penn Image-Guided Interventions Laboratory and Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pa (S.J.H.); Department of Radiology, University of Colorado, Denver, Colo (D.T.J.); Department of Radiology, Ludwig-Maximilian University, Munich, Germany (J.R.); Division of Vascular and Interventional Radiology, Stanford University, Stanford, Calif (D.Y.S.); Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, Fla (B.B.T.); Center for Interventional Oncology, National Cancer Institute, Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Md (B.J.W.); Department of Radiology, Mayo Clinic, Rochester Minn (D.W.); and Department of Radiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (S.N.G.).

Author notes

Address correspondence to J.P.E. (e-mail: erinjerj@ 123456mskcc.org ).

Author information

Joseph P. Erinjeri http://orcid.org/0000-0003-1876-727X

Gosse J. Adema http://orcid.org/0000-0002-6750-1665

Martijn den Brok http://orcid.org/0000-0002-2368-0411

S. Nahum Goldberg http://orcid.org/0000-0003-2940-9822

Article

Accession ID: PMC6604797 Pmcid ID: PMC6604797 Pmc-uid ID: 6604797 Publisher-manuscript ID: 182326

DOI: 10.1148/radiol.2019182326

PMC ID: 6604797

PubMed ID: 31012818

SO-VID: bce7a3e2-5a19-4e59-b78b-748eb8b8820a

History

Date received : 7 October 2018

Date revision requested : 10 December 2018

Date revision received : 12 February 2019

Date accepted : 18 February 2019

Funding

Funded by: National Cancer Institute http://dx.doi.org/10.13039/100000054

Comments

Comment on this article

scite_

Cited by 26

See all cited by